Bioatla Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.21

+0.02 (+10.78%)

As of Feb 8, 2:27 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +4,363.4% upside

Low Target $5.45

Average Target $9.40

High Target $11.97

Current Price $0.21

Current
$0.21

Target
$9.40

$5.45 $9.40 avg $11.97

Scenario Analysis

Bear Case

$5.45

2,487.8%

Low target

Base Case

$9.40

+4,363.4%

Avg target

Bull Case

$11.97

+5,583.8%

High target

Risk/Reward

2.2x

Favorable

Price in Context

52-Week High

$10.55

-98.0% from high

52-Week Low

$5.67

+-96.3% from low

Target vs 52W High

$9.40

-10.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%